Singapore markets close in 4 hours 3 minutes

XBiotech Inc (4XB.BE)

Berlin - Berlin Delayed price. Currency in EUR
Add to watchlist
8.00+0.80 (+11.11%)
At close: 08:08PM CEST
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-36,164
-24,557
-32,900
-17,414
-11,221
Depreciation & amortisation
2,873
1,744
2,614
2,648
2,238
Deferred income taxes
-
-
-
-
-90
Stock-based compensation
5,378
3,262
5,062
4,463
12,581
Change in working capital
8,627
2,719
7,600
79,748
-68,747
Accounts receivable
-1,486
-
0
4,113
-4,113
Accounts payable
424
91
357
-514
-334
Other working capital
-20,215
-19,087
-15,409
65,920
-68,876
Net cash provided by operating activities
-19,286
-18,725
-14,824
69,445
-65,149
Cash flows from investing activities
Investments in property, plant and equipment
-929
-362
-585
-3,525
-3,727
Purchases of investments
-
-
-63,307
0
-
Sales/maturities of investments
61,859
61,859
-
-
-
Net cash used for investing activities
-60,461
61,497
-63,892
-3,525
-3,727
Cash flows from financing activities
Common stock issued
-
-
-
0
-
Common stock repurchased
-
-
-
-
-420,000
Dividends paid
0
-
0
-75,003
0
Other financing activities
-14
-14
-
-
-
Net cash used provided by (used for) financing activities
33
-9
0
-67,008
-409,724
Net change in cash
-78,309
42,717
-79,677
-383
-477,228
Cash at beginning of period
238,877
157,306
236,983
237,366
714,594
Cash at end of period
159,163
200,023
157,306
236,983
237,366
Free cash flow
Operating cash flow
-19,286
-18,725
-14,824
69,445
-65,149
Capital expenditure
-929
-362
-585
-3,525
-3,727
Free cash flow
-20,215
-19,087
-15,409
65,920
-68,876